1. Home
  2. Bills
  3. H.R. 4438

H.R. 4438 · 118th Congress · 2023–2024

John W. Walsh Alpha-1 Home Infusion Act of 2023

H.R. 4438 in the 118th Congress (2023–2024) was introduced on Jun 30, 2023, sponsored by Maria Elvira Salazar with 59 co-sponsors.

During the 118th Congress (2023–2024), Joe Biden was president, and Republicans held the House majority and Democrats the Senate majority.

Status
Introduced
Introduced
Jun 30, 2023
Co-sponsors
59
Policy area
Health

What it does

John W. Walsh Alpha-1 Home Infusion Act of 2023 This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency.

Summary by the nonpartisan Congressional Research Service.

Sponsor

Maria Elvira Salazar (R-FL). Co-sponsors: 33 Democrats, 26 Republicans.

Where it stands

  • IntroducedJun 30, 2023
  • Passed the House—
  • Passed the Senate—
  • Sent to the President—
  • Became law—

Latest action: Referred to the Subcommittee on Health. (Dec 17, 2024)

More bills from Maria Elvira Salazar in the 118th Congress

Other Health bills in the 118th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 4438 (118th Congress): John W. Walsh Alpha-1 Home Infusion Act…,” https://www.capitolreceipts.com/bill/118-hr-4438/john-w-walsh-alpha-1-home-infusion-act-of (accessed 2026-10-17).

Open the interactive version ›